Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA).
- Disclosed ownership: 4.9%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 4.9% ownership in Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 4.9% | 4,004,610 | 0 | 4,004,610 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 4.9% | 4,004,610 | 0 | 4,004,610 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 4.9% | 4,004,610 | 0 | 4,004,610 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 4.9% | 4,004,610 | 0 | 4,004,610 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |